Vor Biopharma's CEO on Genome Engineering of Hematopoietic Stem Cells

Cell & Gene: The Podcast

English - December 22, 2021 09:00 - 19 minutes - 13.2 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: AVROBIO on Patient Advocacy's Role in Clinical Trial Development & Recruitment

Next Episode: RNA's Advantages Over Other Cell Therapies with Cartesian's CSO

We love to hear from our listeners. Send us a message.

Vor Biopharma's CEO Dr. Robert Ang explains the company's lead engineered hematopoietic cell (eHSC) product candidate, genome engineering of HSCs, and the cell manufacturing process needed to leverage genome engineering technologies for the cells they're creating.